CD274 and neoplasm: These results suggested that two main sources of tumor-reactive T cells (pre-existing clonally expanded ITCs and newly infiltrating T cell clonotypes) may be reinvigorated upon blockade of the PD-1–PD-L1 axis in tumor sites and be recruited from peripheral sources.